BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call Transcript

2025-08-06 13:36:36 ET

BeOne Medicines Ltd. (ONC)

Q2 2025 Earnings Call

August 6, 2025 8:00 A.M. ET

Company Participants

Aaron Rosenberg - Chief Financial Officer

Daniel Maller - Head of Investor Relations

John V. Oyler - Co-Founder, Executive Chairman & CEO

Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors

Matt Shaulis - General Manager of North America

Wang Lai - Global Head of R&D

Xiaobin Wu - President, COO & GM of China

Conference Call Participants

Dingding Shi - Jefferies LLC, Research Division

Jessica Macomber Fye - JPMorgan Chase & Co, Research Division

Michael Werner Schmidt - Guggenheim Securities, LLC, Research Division

Reni John Benjamin - Citizens JMP Securities, LLC, Research Division

Sean M. Laaman - Morgan Stanley, Research Division

Yigal Dov Nochomovitz - Citigroup Inc., Research Division

Ziyi Chen - Goldman Sachs Group, Inc., Research Division

Presentation

Operator

Good day, everyone. Welcome to BeOne Q2 2025 Earnings Call Webcast. [Operator Instructions] At this time, I would like to turn the call over to the company.

Daniel Maller

Hello and welcome. Thanks for joining us today. I'm Dan Miller, Head of Investor Relations at BeOne Medicines. Before we begin, please note that you can find additional materials, including a replay of today's webcast and presentation on the Investor Relations section of our website, ir.beonemedicines.com....

Read the full article on Seeking Alpha

For further details see: